Alzheimer's disease genetic and vascular research

Research into Alzheimer’s disease has focused on the relationship between genetic risk factors, amyloid-beta accumulation, and brain atrophy. Early findings indicate that while strictly hereditary cases are rare, genetic mutations in the APP, PSEN1, or PSEN2 genes are linked to early-onset cases, while the APOE ε4 variant serves as a significant risk indicator for late-onset instances. Data from the AMYPAD study suggests that amyloid-beta buildup can predict future brain atrophy in cognitively functional older individuals, a link that is particularly strong in women and those carrying at least one APOE-ε4 allele.

Subsequent studies have expanded on the complexity of the APOE4 variant, noting that its impact varies depending on an individual’s overall APOE profile. For example, certain genetic signals near the DDHD1 gene may actually associate with lower risk specifically in APOE4 carriers. Furthermore, the APOE4 variant has been linked to vascular complications, such as altered lipid metabolism and changes in pericytes. These changes can lead to thickened capillary walls and increased amyloid deposition, suggesting that midlife arterial health may be a factor in preventing cognitive decline.